Cancer News

Recent research from the United Kingdom has shed light on the traditional practice of moxibustion and its potential role in supporting patients undergoing chemotherapy. This ancient technique, which...

In a groundbreaking development for cancer treatment, researchers from Empa and the HOCH Health Ostschweiz hospital network are pioneering the use of nanozymes to enhance the efficacy of brain tumor...

The University of Texas MD Anderson Cancer Center has announced a significant development in its leadership structure with the appointment of Kim Slusser, Ph.D., R.N., as its inaugural Chief Nurse...

Recent research from the University of Georgia highlights a critical healthcare gap: individuals living in low-income neighborhoods are significantly less likely to receive cancer screenings....

A recent study from the University of Georgia has shed light on a troubling trend in cancer screening rates, revealing significant disparities based on socioeconomic status. The findings indicate...

As the landscape of cancer treatment continues to evolve, the upcoming meeting of the FDA's Oncologic Drugs Advisory Committee (ODAC) holds significant potential for patients battling metastatic...

The National Comprehensive Cancer Network (NCCN), a leading alliance of cancer care experts, has garnered notable recognition for its contributions to oncology through various awards and...

In a significant advancement for breast cancer diagnostics, PreludeDx has announced that its AidaBREAST test has received Breakthrough Device designation from the U.S. Food and Drug Administration...

In a significant development for men's health, the National Comprehensive Cancer Network (NCCN) has released updated guidelines emphasizing the importance of prostate cancer screening. These...

Recent updates from the National Comprehensive Cancer Network (NCCN) emphasize a significant shift in the approach to prostate cancer screening. The new patient guidelines aim to clarify the benefits...

Recent research from the Mayo Clinic has unveiled critical mechanisms behind the resistance of certain breast cancers to innovative treatments known as antibody-drug conjugates (ADCs). This discovery...

Researchers at the Mayo Clinic have recently unveiled crucial findings regarding why some breast cancers fail to respond effectively to a promising class of treatments known as antibody-drug...

Recent research from the Mayo Clinic has unveiled critical insights into why certain breast cancers do not respond to a promising class of therapies known as antibody-drug conjugates (ADCs). This...

Recent research from the Mayo Clinic has uncovered critical insights into why certain breast cancers exhibit resistance to a promising class of therapies known as antibody-drug conjugates (ADCs)....

As prostate cancer remains one of the most prevalent forms of cancer among men, new discussions around radiation therapy treatments and their outcomes are emerging. Experts in the field are now...

Recent developments in radiation therapy for prostate cancer have sparked significant interest among healthcare professionals and patients alike. A team of experts has made themselves available to...

Recent discussions among prostate cancer experts highlight significant advancements in radiation therapy treatments and their outcomes, promising new hope for patients facing this challenging...

In a significant recognition of his contributions to cancer research, Dr. Dennis Slamon has been elected to the Association of American Physicians (AAP). His groundbreaking work in identifying the...

Recent advancements in cancer risk prediction are making waves in the field of oncology, particularly with the introduction of a new tool designed to more accurately assess the likelihood of...

Recent funding awards announced by the National Comprehensive Cancer Network® (NCCN®) are set to drive innovative quality improvement initiatives for patients with Chronic Myeloid Leukemia (CML). The...